Sezary Syndrome Market - Top Companies and Manufacturers

Top Featured Companies Dominating the Global Sezary Syndrome Market

GSK plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

The Bristol Myers Squibb Company
F-Hoffmann La Roche Ltd.
Pfizer Inc.
Novartis AG
Johnson and Johnson Services, Inc.
Asher Biotherapeutics, Inc.
Be Biopharma
Eisai Co., Ltd.
Seagen Inc.

Browse Key Market Insights with Data Illustration:

Sezary Syndrome Market Size & Share, Growth Analysis 2037

In the News

The Japan-based Eisai Co., Ltd. has received approval to market and manufacture Remitoro for the treatment of relapsed or refractory PTCL or CTCL. The drug Remitoro is considered a high-need drug.
Seagen Inc. has announced new data for ADCETRIS will be presented at the 64th Annual Meeting and Exposition of the American Society of Hematology (ASH). An updated and interim efficacy and safety clinical trial study for ADCETRIS in classical Hodgkin lymphoma (cHL) and other CD30-expressing lymphomas as well as other rare cancers was presented in the abstracts, including five oral presentations.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of sezary syndrome is estimated at USD 925.66 million.

The sezary syndrome market size was over USD 811.54 million in 2024 and is anticipated to cross USD 2.34 billion by 2037, growing at more than 8.5% CAGR during the forecast period i.e., between 2025-2037. Increasing number of patients suffering from sezary syndrome, a rise in healthcare expenditure, and a growing awareness about the disease will fuel the market growth.

North America industry is predicted to dominate majority revenue share of 37% by 2037, owing to rising medical facilities along with advance healthcare systems in the region.

The major players in the market are GSK plc, The Bristol Myers Squibb Company, F-Hoffmann La Roche Ltd., Pfizer Inc., Novartis AG, Johnson and Johnson Services, Inc., Asher Biotherapeutics, Inc., Be Biopharma, Eisai Co., Ltd., Seagen Inc.

Sezary Syndrome Market - Top Companies and Manufacturers

Top Featured Companies Dominating the Global Sezary Syndrome Market

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the sezary syndrome market?

What are the factors driving the sezary syndrome landscape?

Which region held the largest sezary syndrome industry share?

Who are the key players in the sezary syndrome sector?